Disodium clodronate tetrahydrate is the tetrahydrate of the disodium salt of clodronic acid. It inhibits bone resorption and soft tissue calcification, and is used as an adjunct in the treatment of severe hypercalcaemia associated with malignancy, and in the management of osteolytic lesions and bone pain associated with skeletal metastases. Among its listed roles, it functions as a bone density conservation agent. It is grouped under the following drug class(es): Bisphosphonates. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Bonefos, Sodium clodronate hydrate and Clodronic acid disodium tetrahydrate. Its PubChem CID is 23724874.
Clodronate disodium
| CAS No | 88416-50-6 |
|---|---|
| Molecular Formula | CH10Cl2Na2O10P2 |
| Molecular Weight | 360.91 g/mol |
| Synonyms | disodium;[dichloro-[hydroxy(oxido)phosphoryl]methyl]-hydroxyphosphinate;tetrahydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Disodium clodronate tetrahydrate is the tetrahydrate of the disodium salt of clodronic acid.
The listed CAS number is 88416-50-6.
The listed molecular formula is CH10Cl2Na2O10P2.
The listed molecular weight is 360.91 g/mol.
disodium;[dichloro-[hydroxy(oxido)phosphoryl]methyl]-hydroxyphosphinate;tetrahydrate.
The source lists Bonefos, Sodium clodronate hydrate and Clodronic acid disodium tetrahydrate.